Hacioglu, B. Et Al. 2015. Clinical implications of intratumoral heterogeneity ofHER2gene amplification in locally advanced HER2-positive breast cancer patients. FUTURE ONCOLOGY , vol.11, no.18 , 2495-2497.

Hacioglu, B., AKIN, S., SEVER, A. R., & Altundag, K., (2015). Clinical implications of intratumoral heterogeneity ofHER2gene amplification in locally advanced HER2-positive breast cancer patients. FUTURE ONCOLOGY , vol.11, no.18, 2495-2497.

Hacioglu, Bekir Et Al. "Clinical implications of intratumoral heterogeneity ofHER2gene amplification in locally advanced HER2-positive breast cancer patients," FUTURE ONCOLOGY , vol.11, no.18, 2495-2497, 2015

Hacioglu, Bekir Et Al. "Clinical implications of intratumoral heterogeneity ofHER2gene amplification in locally advanced HER2-positive breast cancer patients." FUTURE ONCOLOGY , vol.11, no.18, pp.2495-2497, 2015

Hacioglu, B. Et Al. (2015) . "Clinical implications of intratumoral heterogeneity ofHER2gene amplification in locally advanced HER2-positive breast cancer patients." FUTURE ONCOLOGY , vol.11, no.18, pp.2495-2497.

@article{article, author={Bekir Hacioglu Et Al. }, title={Clinical implications of intratumoral heterogeneity ofHER2gene amplification in locally advanced HER2-positive breast cancer patients}, journal={FUTURE ONCOLOGY}, year=2015, pages={2495-2497} }